Sanofi (SNY) offered commitments to address competition concerns over a communication campaign that has possibly disparaged a competing flu vaccine, the European Commission said Wednesday.

The regulatory body is now collecting third-party feedback on the proposed commitments to decide if they satisfy the antitrust case, the commission said.